How about BGI s non invasive DNA

I didn't get the result after two weeks, and when I was about to go to inquire, I suddenly received a call from the hospital** saying that because of the problem of hcg value, it could not be measured, and I needed to take a new blood test. What does that mean? I've gone to have my blood drawn again, and I'm very nervous and nervous.

God must bless the baby to be okay!

I regret more and more that I did it at BGI, if I had to do it again, I wouldn't do it, I would change to another one, and if the money was not returned, it would be regarded as a donation for charity, and I really couldn't afford it with them.

I can't afford to hurt, and I'm still waiting for 10 working days.

It's so slow, I only finished it yesterday, and I'm suffering.

Sometimes there will be a delay in the construction period.

Not a lie. BGI. is a company specializing in life sciences.

of cutting-edge institutions in science and technology. A scientific research method based on learning, research and application. It involves scientific and technological research at the molecular and genetic levels such as human, medical, agricultural, animal husbandry, and endangered animal protection.

On December 18, 2015, the China Securities Regulatory Commission (CSRC) announced the "Application Draft" for BGI's proposed listing on the Growth Enterprise Market (GEM), and the company's listing sponsor was CITIC**.

On July 2, 2014, according to the State Food and Drug Administration, the second-generation gene sequencing diagnostic products were approved for marketing.

BGI became the first CFDA-approved non-invasive prenatal genetic testing institution.

On June 30, 2014, the State Food and Drug Administration approved the registration of BGISEQ-1000 gene sequencer, BGISEQ-100 gene sequencer, fetal chromosomal aneuploidy (T21, T18, T13) detection kit (combined with probe-anchored ligation sequencing method) and fetal chromosomal aneuploidy (T21, T18, T13) detection kit (semiconductor sequencing method) after review. This is the first second-generation gene sequencing diagnostic product approved and registered by the State Food and Drug Administration.

This batch of products can perform non-invasive prenatal examination and auxiliary diagnosis of fetal chromosomal aneuploidy diseases such as trisomy 21, trisomy 18 and trisomy 13 by gene sequencing of free gene fragments in the peripheral blood plasma of high-risk pregnant women with a gestational age of more than 12 weeks.

BGI is the first company, probiotics are Yakult, that is, the common people often drink big yogurt drinks, how many years have they been fooling, and they have been fooling again by changing the vest, and Yin Ye, the chairman of the company, has been completely exposed by well-known experts.

First of all, BGI is a third-party testing organization, BGI is a scientific and technological research company specializing in life sciences, and its research scope covers humans, medicine, agriculture, animal husbandry, endangered animal protection, etc., and provides technical support at the molecular genetic level. The company has successively completed a number of scientific research works with international advanced level, such as the "China Part" of the International Human Genome Project (1%), the International Human Haplotype Map Project (10%), the Rice Genome Project, and Yanhuang No. 1.

You can go to the official website of BGI to check, there are still many people around you who have done non-invasive prenatal genetic testing of BGI.

The genetic testing industry as a whole is all about fooling and fortune telling. My friends studied qPCR for a few days, and then set up a genetic testing company, cooperated with BGI, all kinds of talent genes, all kinds of inconsequential genetic testing, and financed a lot, all of which were invested in the law to fool people together, and saw that it was profitable, and set up many branches and branches, all of which were using a few cheap instruments to tell fortunes for people's science and technology. Now when the mechanism of the disease has not been studied clearly, all genetic testing is a foolish probability.

BGI took the lead.

Did you go for non-invasive genetics? No problem, is it there? The Tang sieve I went to check yesterday was 1? How's that: Doctor 380 also said I'm on the threshold Hello.

Genetic testing is a tech lie in China, whether it's grandstanding and bragging about genetics or fooling "health" companies. The local tyrants have money, buy a few sets of equipment back, but there is no database, saying that there is only a little bit, less than a few hairs in the United States, so it is not actually useful, but you have to make money, hype, high-tech concepts, they don't understand, do you understand? But the local tyrants dare to hype, and some people believe it, and the poor and kind Chinese people hate the ** institutions that do not act or turn a blind eye to the benefits.

Now that the national policies are all supported, how can it deceive people.

BGI testing, on the good test network, one-click order, direct to BGI laboratory testing. BGI Testing can be trusted.

Collect IQ tax Collect IQ tax Collect IQ tax.

If the result of the chromosomal trisomy test is positive or high-risk, the results of other chromosomal tests are abnormal, and the insured person receives medical expenses for prenatal diagnosis.

For example, amniocentesis, percutaneous umbilical vein puncture, karyotype analysis and chromosomal fluorescence in situ hybridization (FISH) will be reimbursed by Chinese Life in accordance with the agreement, with a maximum payment of RMB 2,500, and the insurer's insurance liability will be terminated.

If the trisomy test result is negative or low-risk, the baby born to the insured person will be definitively diagnosed with the disease of chromosomal trisomy by karyotyping by a provincial or municipal specialist within one year of birth.

At the same time, if the paternity test confirms that the child is the biological child of the pregnant woman, Chinese Life will pay the insured an insurance premium of 400,000 yuan according to the insurance contract, and the insured shall not recover any other expenses from our company after the termination of the insurer's insurance liability.

Down syndrome, also known as trisomy 21, is a chromosomal abnormality (an extra chromosome 21).

60% of the children were aborted in the early stage of the fetus, and the survivors had obvious mental retardation, special facial features, growth and development disorders, and multiple malformations.

According to international standards, a screening value of less than 1 270 indicates a relatively low risk. However, if the danger is higher than 1 270, it means that the risk of "Down's child" is higher. So what should I do if the pregnant mother's Tang screening test result is written as "high risk"?

First of all, you must adjust your mentality. Because the risk factor of trisomy 21 is 1 100, which means that the probability of a mutation on chromosome 21 to produce a congenital foolish fetus is 1 100, maybe you are the 1 100 with the problem, or maybe the 99 100 with no problem.

Secondly, do an amniocentesis as soon as possible under the doctor's arrangement. Amniocentesis is the "golden indicator" for examining "Down syndrome baby", but it is an invasive and risky examination method, so it is generally used to determine the final Tang screening results. Amniocentesis is usually done only for high-risk pregnant women.

There is currently no effective method for Down syndrome, and if the results of amniocentesis are still high-risk, it is best to terminate the pregnancy.

Insurance Liability. If the trisomal test result is positive or high-risk, and the results of other chromosomal tests are abnormal, the medical expenses incurred by the insured for prenatal diagnosis, such as amniocentesis, percutaneous umbilical vein puncture, karyotype analysis and chromosomal fluorescence in situ hybridization (FISH), will be reimbursed by Chinese Life in accordance with the agreement, with a maximum payment of RMB 2,500, and the insurance liability of the insurer will be terminated.

If the trisomy test result is negative or low risk, and the baby born to the insured is clearly diagnosed with chromosomal trisomy disease by a provincial or municipal specialist doctor using chromosomal karyotype analysis within one year after birth, and the child is confirmed to be the biological child of the pregnant woman by paternity testing, Chinese Life will pay the insured an insurance premium of 400,000 yuan according to the insurance contract, and the insured shall not recover any other expenses from our company after the termination of the insurer's insurance liability.

Accurate. Regular places are fully automatic instrument operation. Listen to your doctor's advice, health matters.

DNA testing is related to:

DNA analysis is mainly used to identify genetic diseases caused by a single gene abnormality, such as Huntington's disease. The cells analyzed for DNA analysis are derived from blood or fetal cells.

Genetic testing can be divided into the following five categories:

1.Genetic screening.

Testing is mainly for specific groups or the entire population. Most are through prenatal or neonatal genetic testing.

2.Reproductive genetic testing.

It can be used during the IVF stage to screen the embryo for genetic mutations and prevent the fetus from having genetic diseases.

3.Diagnostic tests.

Most are used to assist in clinical medication guidance.

4.Gene carrier testing.

5.Testing before symptoms appear.

The purpose of testing is to find out if people who are currently well healthy have a mutated gene that is closely linked to the development of a particular disease.

Clinical significance. 1.It is used for the diagnosis of diseases.

For example, the diagnosis of Mycobacterium tuberculosis infection, which used to rely mainly on sputum, stool or blood culture, and the entire test process took more than two weeks, now the method of genetic diagnosis is adopted, which not only greatly improves the sensitivity, but also can obtain results in a short time.

2.Know if you have the genes that cause your familial disease,** your risk.

Data confirm that 10% and 15% of cancers are related to heredity, and many diseases such as diabetes and cardiovascular and cerebrovascular diseases are related to genetic factors. For example, people with cancer or polygenic genetic diseases (such as Alzheimer's disease, hypertension, diabetes, etc.) can find out the genetic genes that cause the disease, and then they can make targeted lifestyle adjustments to prevent or delay the occurrence of diseases.

3.Choose your medications correctly and avoid drug abuse and adverse drug reactions.

Due to individual genetic differences, different people will react differently to foreign substances, so some patients may experience drug allergies, redness, swelling and rashes when using normal doses of drugs. According to the results of genetic testing, a specific program can be formulated to scientifically guide the use of drugs and avoid drug toxicity and side effects.

The accuracy rate of non-invasive is quite high I have a sister who chose to do non-invasive after the high-risk Tang sieve There is no problem Now the baby is very good I think it is useless to do Tang Sieve When the doctor explained, he said that high risk is not necessarily a problem Low risk is not necessarily a problem I wondered Then why do we do it?? I did it for nothing...

If non-invasive is made to be low-risk, it is much more confident than the low-risk Tang sieve, so many low-risk hemp in Tang Sieve are relieved, and non-invasive and low-risk hemp can be more assured.

Tang screen is a risk index calculated based on factors such as maternal age, weight, gestational age, etc. The accuracy rate is 60% to 80%, and there is a 5% false positive rate. You can consider doing non-invasive, anyway, my friend said that it is quite good, only 5ml of blood can be drawn, and there is no harm to yourself.

The non-invasive accuracy rate reaches more than 99%, and I wish the baby good health

Did you go for non-invasive genetics? No problem, is it there? The Tang sieve I went to check yesterday was 1? How's that: Doctor 380 also said I'm on the threshold Hello.

Hello, may I ask where you are? The Tang sieve I went to check yesterday was 1:380, and the doctor also said that I was at a critical value, did you go for non-invasive genes? What do you think? No problem, right?

BGI Technology Services**** (BGI) is a subsidiary of BGI, the world's leading genomics research institution.

BGI Technology (full name Shenzhen BGI Technology Services****) is a subsidiary of BGI.

Adhering to the industrial concept of "scientific and technological cooperation and service", it was established in April 2012. Based on BGI's rich scientific research experience and advanced technological achievements, BGI has established an advanced scientific research platform, a strict quality system, standardized and personalized data analysis, and a high-quality service process to provide scientific research cooperation and services for researchers engaged in the fields of biology, agriculture, medicine and other life sciences. Headquartered in Shenzhen, China, BGI has a total of 1,500 employees and a global service network with business centers, branches and offices in Europe, the Americas and the Asia-Pacific region.

With the world's leading large-scale sequencing computing platform and advanced bioinformatics analysis technology, relying on partners in human health, drug research and development, animal and plant research, molecular breeding, microbial research and other fields, BGI has provided outstanding scientific research services for a series of large-scale genomic research projects and international cooperation projects, such as: the International Thousand Genomes Project, diabetes-related genes and mutation research, the International Cancer Genome Project, the wheat, corn, silkworm and other animal and plant genome projects, Human intestinal microbial genome research project, as well as human genome and silkworm genome methylation research, etc. In 2012, the turnover reached 100 million yuan, and as of December 12, there were more than 20,000 partners, more than 4,000 cooperative units, and participated in the publication of more than 250 scientific research**, including more than 40 academic papers in top journals such as science and nature.